Status:
UNKNOWN
Chronic Granulomatous Disease Study in China
Lead Sponsor:
Shanghai Children's Medical Center
Conditions:
Granulomatous Disease, Chronic
Eligibility:
All Genders
1-18 years
Brief Summary
CGD is a rare inherited primary immunodeficiency which is caused by the defect in one of the subunits of NADPH oxidase complex.We tend to collect and analyze Chinese CGD patients who are diagnosed in ...
Eligibility Criteria
Inclusion
- x-linked and AR-linked Chronic Granulomatous Disease
- history of life-threatening severe infections
- A functional assay demonstrating abnormal NADPH oxidase function or clinical history consistent with CGD
Exclusion
- Presence of other primary immunodeficiency syndromes that do not meet the clinical and laboratory criteria for CGD.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02231996
Start Date
September 1 2014
Last Update
September 5 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai children's medical center
Shanghai, Shanghai Municipality, China, 200127